You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 14, October 12, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Capitol Health Call
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Law and Medicine
 •Substance Abuse/ Alcoholism
 •Alert me on articles by topic

Limit Lifted

Mike Mitka

JAMA. 2005;294:1752.

Since this article does not have an abstract, we have provided the first 137 words of the full text and any section headings.

Legislation increasing the number of patients with opioid addiction that group medical practices are allowed to treat was signed into law September 2 by President Bush.

Previously, the Drug Addiction Treatment Act of 2000 expanded access to treatment for opioid addiction beyond such traditional venues as large public clinics by allowing office-based dispensing and prescribing of Schedule III drugs, such as buprenorphine. But the legislation placed a limit of 30 patients per physician or 30 patients per group practice, in part to allay fears of people residing near such practices that drug-addiction clinics were springing up in the neighborhood. The new law maintains the 30 patient per physician limit while eliminating the 30 per group practice ceiling.

The change was supported by the American Psychiatric Association and the National Association of State Controlled Substances Authorities.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.